Introduction {#sec1-1}
============

Osteoarthritis (OA) is considered a cumulative result of mechanical and biological events caused by an imbalance between catabolic and anabolic processes in articular joint tissue \[[@ref1]\]. At present, the development of OA is thought to be regulated largely by excess matrix metalloproteinase (MMP), which contributes to the degradation of extracellular matrices, such as MMP-1 and MMP-3 which play an important role in the development of OA by decreasing extracellular matrix \[[@ref2]\], where this MMP is induced by inflammatory mediators, such as interleukin-1-beta (IL-1β) and tumour necrosis factor alpha (TNF-α) in tissue and OA joint fluid \[[@ref3]\]. So far there are no drugs available to guarantee a complete cure and the possibility of recurrence from OA.

Mesenchymal stem cells (MSCs) are promising candidates for cartilage regeneration and OA therapy because they have a chondrogenic potential and the ability to form extracellular matrices \[[@ref4]\]. Also, MSC has an immunomodulatory and trophic capacity by secreting anti-inflammatory factors and growth factors \[[@ref5]\], which might improve the inflammatory and catabolic aspects of OA. Monosodium iodoacetate injection (MIA) to intra articular has been studied extensively as a model for OA in animals \[[@ref6]\], \[[@ref7]\] and is regarded as a suitable model and resembles a phenomenon observed in human OA \[[@ref8]\].

Matrix metalloproteinase-1 is one of the protease enzymes that acts to degrade the components of the main cartilage matrix, such as collagen, aggrecan, link protein, and cartilage oligomer proteins \[[@ref9]\], \[[@ref10]\] while IL-4 and other cytokines are secreted in large amounts to counter the inflammatory response when Th2 dominates inflamed tissue because these immunomodulatory cytokines can reduce the production and activity of proinflammatory cytokines which are classified as inhibitors \[[@ref11]\].

This study aims to prove the influence of Mesenchymal Stem Cell Wharton Jelly on decreasing MMP-1 levels and increasing IL-4 which is a specific target as a target component in cases of osteoarthritis in vivo.

Material and Methods {#sec1-2}
====================

Animal and Experimental Design {#sec2-1}
------------------------------

Male, white rats (*Rattus novergicus*) with a weight ranging from 200-250 grams as experimental animals placed in clean, disinfected and pathogen-free cages and given standard food in the form of pellets and drinking in ad libitum. Trial animals adapted first for 1 week before treatment. Induction of osteoarthritis conducted with 300 μg intra-articular injection of monosodium iodoacetate (MIA) (Sigma Aldric, USA) in 50 μl of saline solution (0.9% NaCl) sterile (12) single into the right knee joint rats anaesthetized by intraperitoneal injection of xylazine 10 mg/kg and ketamine 20 mg/kg uses insulin syringe with a needle (*needle*) 27G. 32 osteoarthritis male, white rats (three weeks after MIA induction) were divided into 2 treatment groups (n = 16): Control group and MSC-WJ group. MSC group-WJ is given 50 μl MSC-WJ with a dose of 1 x 10^6^ cells into the right knee joint and a control group given 50 μl complete medium after anaesthetized.

Mesenchymal Stem Cell Wharton Jelly was obtained from the Indonesian Medical Education and Research Institute (IMERI) Faculty of Medicine, University of Indonesia. Based on the analysis of flow cytometry, MSC-WJ used for this therapy had CD73-APC cell surface expression 99.8%, CD105-PerCP-Cys5.5 95% and CD90-FITC 99.9%. Rats were sacrificed after 3 weeks of treatment. Serum and knee joint were taken and then analysed.

Analysis of Flow Cytometry {#sec2-2}
--------------------------

Mesenchymal Stem Cell Wharton Jelly was obtained from the Indonesian Medical Education and Research Institute (IMERI) Faculty of Medicine, University of Indonesia. Based on the analysis of flow cytometry, MSC-WJ used for this therapy had CD73-APC cell surface expression 99.8%, CD105-PerCP-Cys5.5 95% and CD90-FITC 99.9%. The photocell was taken use Nikon Ti-S microscope. Scale bar: 500 μm.

Histological Analysis {#sec2-3}
---------------------

The right knee joint from the two groups and the left knee joint (normal) was cut and fixed in 4% formalin for 1 weekend calcified with formic acid (5%) for 3 days. The specimen then underwent automatic network processing for 24 hours. The tissue planted in paraffin and cutting using a microtome with a thickness of 5 μm. Ribbon cutting results were placed on the surface of warm water with a temperature of 45°C to remove folds on the ribbon due to cutting. Every ribbon was stained with Hematoxylin and Eosin (H&E).

Measurement of serum MMP-1 and IL-4 by ELISA {#sec2-4}
--------------------------------------------

Blood was taken from sinus periorbital and centrifuged at 3000 rpm for 15 minutes. The collected serum was stored at -80°C until measurement. Serum MMP-1 and IL-4 levels were measured by an ELISA kit (Bioassay Technology Laboratory, China). All samples are measured in duplicate.

Examination of MMP-1 Levels (Work protocol based on rat MMP-1 ELISA Kit) {#sec2-5}
------------------------------------------------------------------------

Prepare all reagents, standard solutions and samples as instructed. Bring all reagents to room temperature before use. The assay is performed at room temperature. Determine the number of strips required for the assay. Insert the strips in the framers for use. The unused strips should be stored at 2-8°C. Add 50 µL standard well. Add 40 µL sample to sample wells and then add 10 µL anti-MMP-1 antibody to sample wells, then add 50 µL streptavidin-HRP to sample wells and standard wells (Not blank control well). Mix well. Cover the plate with a shaker. Incubate 60 minutes at 37°C. Removed the sealer and wash the plate 5 times with wash buffer. Soak wells with at least 0,35 ml wash buffer for 30 seconds to minute for each wash. For automated washing, aspirate all wells and wash 5 times with wash buffer, overfilling wells with wash buffer. Blot the plate onto paper towels or other absorbent material. Add 50 µL substrate solution A to each well and then add 50 µL substrate solution B to each well. Incubate plate covered with a new sealer for 10 minutes at 37°C in the dark. Add 50 µL stop solution to each well; the blue colour will change into yellow immediately. Determine the optical density (OD value) of each well immediately using a microplate reader set a 450 nm within 30 min after adding the stop solution.

Examination of IL-4 Levels (Work protocol based on rat IL-4 ELISA Kit) {#sec2-6}
----------------------------------------------------------------------

Prepare all reagents, standard solutions and samples as instructed. Bring all reagents to room temperature before use. The assay is performed at room temperature. Determine the number of strips required for the assay. Insert the strips in the framers for use. The unused strips should be stored at 2-8°C. Add 50 µL standard well. Add 40 µL sample to sample wells and then add 10 µL anti-MMP-1 antibody to sample wells, then add 50 µL streptavidin-HRP to sample wells and standard wells (Not blank control well). Mix well. Cover the plate with a shaker. Incubate 60 minutes at 37°C. Removed the sealer and wash the plate 5 times with wash buffer. Soak wells with at least 0,35 ml wash buffer for 30 seconds to minute for each wash. For automated washing, aspirate all wells and wash 5 times with wash buffer, overfilling wells with wash buffer. Blot the plate onto paper towels or other absorbent material. Add 50 µL substrate solution A to each well and then add 50 µL substrate solution B to each well. Incubate plate covered with a new sealer for 10 minutes at 37°C in the dark. Add 50 µL stop solution to each well; the blue colour will change into yellow immediately. Determine the optical density (OD value) of each well immediately using a microplate reader set a 450 nm within 30 min after adding the stop solution.

Research Ethics {#sec2-7}
---------------

This study was already passed the ethics clearance and has been approved by the Ethics Committee of the Faculty of Medicine, Andalas University, Padang with registration number: 549/KEP/FK/2017.

Statistical analysis {#sec2-8}
--------------------

Data is presented in mean and elementary forms. The statistical analysis used is SPSS 18.0. The statistical test used is an independent t-test. The value of p \< 0.05 was said to be statistically significant.

Result {#sec1-3}
======

A study of 32 osteoarthritis rats induced with monosodium iodoacetate (MIA) for 3 weeks was carried out. OA rats were divided into 2 groups, namely the control group and the group treated with MSC-WJ ([Figure 1](#F1){ref-type="fig"}). Three weeks after MSC therapy, termination was done at the expense of experimental animals. Then a histopathological examination of mouse right knee (OA) was carried out. Examination of the levels of MMP-1 and IL-4 was carried out in the serum of rats by ELISA.

![Data on Characteristics of Mesenchymal Stem Cells Wharton Jelly. (A) Cells MSC-WJ reach confluence. Scale bar: 500 µM. Photographs of cells taken using a Nikon Ti-S microscope; (B) Data flow cytometry. Forward scatter (FCS) plot&side scatter (SSC) plot. Population gated events (P1): 20,000; (C) Cell surface markers expression: CD73-APC 99.8% and CD105- PerCP-Cy5.5 95%; (D) Cell surface markers expression: CD90-FITC 99.9% and Lin (-) - PE 0.4%](OAMJMS-7-529-g001){#F1}

Histopathology examination {#sec2-9}
--------------------------

After the bone portion of the rat's knee is obtained preserved with formalin buffer, Histopathological examination was carried out using Hematoxylin-Eosin staining; the results are shown in [figure 2](#F2){ref-type="fig"}. The results we can see in tissue reactions are changes in the thickness of cartilage and the number of chondrocytes.

![Microscopic joint tissue of experimental animals, showed joint fragility (Kh), bone tissue (Os) in normal rats, osteoarthritis (OA), and OA + MSC-WJ. Objective hematoxylin-eosin](OAMJMS-7-529-g002){#F2}

Histopathological results show joint tissue with the surface consisting of cartilage with chondrocyte cells. In the OA group, there were areas with a thickness of cartilage that was thinner than normal animals and OA animals injected by MSC-WJ ([Figure 2](#F2){ref-type="fig"}).

In addition to changes in the thickness of the cartilage, histopathological results also showed an increase in chondrocyte cell density in the OA mouse group compared to normal rats. In the OA group, of rats given MSC-WJ, the density of chondrocyte was close to the mean of normal rats.

ELISA examination {#sec2-10}
-----------------

The blood obtained from the centrifuged animal is then obtained serum. Serum before analysis was stored in a refrigerator temperature of -80°C. The serum obtained was analysed for MMP-1 and IL-4 levels carried out in the Biomedical laboratory FK Unand.

The measurement of MMP-1 and IL-4 levels were carried out in normal rat, and the mean levels of MMP-1 and IL-4 were 1.62 ng/ml and 34.27 ng/ml. Based on the results of the normality test the data showed that the two research variables namely MMP-1 and IL-4 were normally distributed (p \> 0.05). Thus, furthermore, parametric tests (free t-test) can be carried out.

Effect of MSC-WJ on serum MMP-1 levels in OA rats treated with MSC-WJ {#sec2-11}
---------------------------------------------------------------------

The measurement of MMP-1 levels by ELISA method showed that the serum MMP-1 levels of OA rat treated with MSC-WJ were higher than those not treated which can be seen in [Figure 3](#F3){ref-type="fig"}.

![Boxplot graph of rat serum MMP-1 levels](OAMJMS-7-529-g003){#F3}

The difference in MMP-1 levels between serum of rats treated with MSC-WJ and control can be seen in [Table 1](#T1){ref-type="table"}.

###### 

Differences in mean levels of MMP-1 by group

  Groups    MMP-1 levels (ng/ml) (Mean ± SD)   P value
  --------- ---------------------------------- ---------
  Control   2.63 ± 0.55                        0.001
  MSC-WJ    3.96 ± 0.81                        

[Table 1](#T1){ref-type="table"} showed that there are differences in MMP-1 levels based on treatment. Increased levels of MMP-1 in the group treated with MSC-WJ from the control group. There were significant differences, between MSC-WJ with control (p \< 0.05).

Effect of MSC-WJ on IL-4 levels in serum of OA rats {#sec2-12}
---------------------------------------------------

The results of measurement of IL-4 levels by ELISA method showed that the serum IL-4 levels of OA rats treated with MSC-WJ were higher than those not treated with bivariate tests which can be seen in [Figure 4](#F4){ref-type="fig"}.

![Boxplot graph of rat serum IL-4 levels](OAMJMS-7-529-g004){#F4}

The difference in IL-4 levels between serum of rats treated with MSC-WJ and control can be seen in [Table 2](#T2){ref-type="table"}.

###### 

Mean differences in IL-4 levels by group

  Groups    IL-4 Levels (ng/l) (Mean ± SD)   P value
  --------- -------------------------------- ---------
  Control   43.90 ± 4.99                     0.027
  MSC-WJ    47.95 ± 4.88                     

[Table 2](#T2){ref-type="table"} showed that there are differences in IL-4 levels based on treatment. Increased IL-4 levels in the group treated with MSC-WJ from the control group. There were significant differences, between MSC-WJ with control (p \< 0.05).

Discussion {#sec1-4}
==========

The results showed that MIA induction in rats with a single dose of 300 μg after 3 weeks showed the reduced thickness of cartilage. The results of this study are also the same as those conducted by Janusz *et al.*, (2001) regarding the effect of MIA on rat cartilage, wherein the study there was also reduced of cartilage in the surrounding area after one week of MIA induction \[[@ref13]\].

This reduced cartilage occurs due to the loss of proteoglycans that build up the matrix. Also, the results of this study also showed a form of reactive chondroblast cell proliferation, so that cell densities were higher than those of OA rat cartilage that was not treated with MSC-WJ.

The results of the serum analysis using the ELISA method showed a tendency to increase serum MMP-1 and IL-4 levels compared to the serum of non-induced (normal) rat. This increase is due to chondrocyte cells and immune cells stimulated by inflammatory cytokines (IL-β and TNF-α) whose levels increase when inflammation occurs due to MIA induction.

Increased matrix-degrading enzymes and anti-inflammatory cytokines after MIA induction showed that rats experienced osteoarthritis. Induction of MSC-WJ in OA rat for 3 weeks showed a thickness of joint cartilage close to the thickness of normal cartilage and showed lower cell density closer to normal compared to OA rat. This shows the appearance of tissue repair in osteoarthritis by MSC-WJ.

Matrix metalloproteinase-1 (MMP-1) {#sec2-13}
----------------------------------

Matrix metalloproteinase-1 is one of the protease enzymes that act to degrade the components of the main cartilage matrix, such as collagen, aggrecan, link protein, and cartilage oligomer proteins \[[@ref14]\], \[[@ref15]\]. This enzyme also functions to increase the proliferation and migration of MSCs \[[@ref16]\]. MMP-1 increases production in synovial membranes, synovial fluid, and human cartilage that undergo OA \[[@ref17]\], also in the serum of OA rat significantly \[[@ref2]\]. The release of MMP-1 protein by human articular chondrocyte is stimulated by IL-1β \[[@ref18]\].

This study showed that the serum MMP-1 levels of OA rat treated with MSC-WJ were higher than those not treated. Research by Saulnier *et al.*, (2015) showed that the administration of MSC in rabbits OA had was not effective in reducing the expression of MMP-1 after 2 weeks of injection with MSC, but effectively reduced MMP-1 expression after 8 weeks of injection \[[@ref19]\].

The results of this study indicate that MSC-WJ therapy has not been effective in reducing MMP-1 levels within 3 weeks after injection. Possibly in this period, MSC-WJ was still synthesising and releasing MMP-1 which is needed for the apoptosis of chondrocyte and synovial cells \[[@ref20]\], the process of MSC migration and proliferation \[[@ref16]\] and differentiation. Ho *et al.*, (2009) showed that MMP-1 plays an important role in the MSC migration function, which operates through MMP1-PAR1 axis signalling \[[@ref21]\]. According to Voronkina *et al.*, (2017) that the involvement of MMP-1 is in the process of MSC differentiation, namely the increase in MMP-1 activity during the differentiation process \[[@ref22]\].

The high levels of MMP-1 in OA mice treated with MSC-WJ were compared with OA mice that were not treated because in this period MSC expressed MMP-1 constitutively \[[@ref23]\]. It is possible that MSC-WJ requires MMP-1 in repairing cell damage because it involves the process of apoptosis, migration and MSC differentiation and proliferation.

Interleukin-4 (IL-4) {#sec2-14}
--------------------

Interleukin-4 (IL-4) is an anti-inflammatory cytokine that plays a role in stimulating the proliferation of B cells and T cells and encourages differentiation of CD4 + T cells into Th2. IL-4 also plays a key role in regulating humoral and adaptive immunity. IL-4 and other cytokines are secreted in large amounts to counter the inflammatory response when Th2 dominates inflamed tissue. Because these immunomodulatory cytokines can reduce the production and activity of proinflammatory cytokines which are classified as inhibitors \[[@ref11]\].

Research by Hui *et al.*, (2005) found that IL-4 was reported to play a role in the regulation of ADAMTS-4 in chondrocyte, although the exact mechanism has not been explained \[[@ref24]\]. The proteins secreted by rat MSC and humans are chemokines, cytokines, growth factors and protease inhibitors \[[@ref25]\], including IL-4, IL-10, and IL-13 which are anti-inflammatory cytokines \[[@ref26]\].

In this study, it was found that IL-4 levels were higher in the serum of OA rat treated with MSC-WJ compared with those not treated. The same thing was found in the study of Kay *et al.*, (2017) which showed that IL-4 expression was higher in arthritis rats given MSC compared to those not given \[[@ref27]\]. Whereas Yan *et al.*, (2017) research found that serum IL-4 levels of arthritis rats treated with MSC were compared with serum of non-treated arthritis rats, but the difference was not significant \[[@ref28]\]. Chai *et al.*, (2016) also found the same thing that UC-MSC can increase IL-4 in liver fibrosis both in vitro and in vivo \[[@ref29]\].

Increased levels of IL-4 in the serum of OA mice show that MSC-WJ can increase the immunosuppressive activity of Th2 cells. MSC increases anti-inflammatory cytokines such as IL-4 which have anti-inflammatory effects through inhibition of the NF-κB cascade, which contributes to the regulation of proinflammatory cytokines \[[@ref30]\]. MSC plays an important role in cartilage repair through direct differentiation into chondrocyte and paracrine effects \[[@ref31]\], \[[@ref32]\].

Information about the increase in expression in the form of serum IL-4 proteins in this study is important for the development of MSC-WJ as a therapy for osteoarthritis. The development of MSC-WJ as a therapy for osteoarthritis is quite promising. Differences in IL-4 levels between serum of rats treated and those not treated with MSC-WJ proved that MSC-WJ had a therapeutic effect. Thus, the information obtained encourages further studies of MSC-WJ as a treatment for OA.
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